Year |
Citation |
Score |
2019 |
Oshima K, Han X, Ouyang Y, El Masri R, Yang Y, Haeger SM, McMurtry SA, Lane TC, Davizon-Castillo P, Zhang F, Yue X, Vivès RR, Linhardt RJ, Schmidt EP. Loss of endothelial sulfatase-1 after experimental sepsis attenuates subsequent pulmonary inflammatory responses. American Journal of Physiology. Lung Cellular and Molecular Physiology. PMID 31461325 DOI: 10.1152/Ajplung.00175.2019 |
0.414 |
|
2017 |
Yue X. Epithelial Deletion of Sulf2 Exacerbates Bleomycin-induced Lung Injury, Inflammation and Mortality. American Journal of Respiratory Cell and Molecular Biology. PMID 28657777 DOI: 10.1165/Rcmb.2016-0367Oc |
0.304 |
|
2016 |
Yue X, Lin X, Yang T, Yang X, Yi X, Jiang X, Li X, Li T, Guo J, Dai Y, Shi J, Wei L, Youker KA, Torre-Amione G, Yu Y, et al. Rnd3/RhoE Modulates Hypoxia-Inducible Factor 1α/Vascular Endothelial Growth Factor Signaling by Stabilizing Hypoxia-Inducible Factor 1α and Regulates Responsive Cardiac Angiogenesis. Hypertension. PMID 26781283 DOI: 10.1161/Hypertensionaha.115.06412 |
0.374 |
|
2015 |
Auduong L, Hogan EA, Yue X. Role of sulf2 in alveolar epithelial injury and repair. Annals of the American Thoracic Society. 12: S73-4. PMID 25830846 DOI: 10.1513/Annalsats.201406-267Mg |
0.316 |
|
2008 |
Yue X, Li X, Nguyen HT, Chin DR, Sullivan DE, Lasky JA. Transforming growth factor-beta1 induces heparan sulfate 6-O-endosulfatase 1 expression in vitro and in vivo. The Journal of Biological Chemistry. 283: 20397-407. PMID 18503048 DOI: 10.1074/Jbc.M802850200 |
0.306 |
|
2005 |
Dai Y, Yang Y, MacLeod V, Yue X, Rapraeger AC, Shriver Z, Venkataraman G, Sasisekharan R, Sanderson RD. HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo. The Journal of Biological Chemistry. 280: 40066-73. PMID 16192265 DOI: 10.1074/Jbc.M508136200 |
0.342 |
|
2005 |
Dai Y, Yang Y, MacLeod V, Yue X, Rapraeger AC, Shriver Z, Venkataraman G, Sasisekharan R, Sanderson RD. Extracellular Endosulfatases (Sulfs) Inhibit Myeloma Tumor Growth In Vivo. Blood. 106: 3386-3386. DOI: 10.1182/Blood.V106.11.3386.3386 |
0.309 |
|
2004 |
Tomanek RJ, Zheng W, Yue X. Growth factor activation in myocardial vascularization: therapeutic implications. Molecular and Cellular Biochemistry. 264: 3-11. PMID 15544030 DOI: 10.1023/B:Mcbi.0000044369.88528.A3 |
0.609 |
|
2004 |
Yue X, Schultheiss TM, McKenzie EA, Rosenberg RD. Role of heparan sulfate in dextral heart looping in chick. Glycobiology. 14: 745-55. PMID 15070861 DOI: 10.1093/Glycob/Cwh083 |
0.307 |
|
2003 |
Tomanek RJ, Lund DD, Yue X. Hypoxic induction of myocardial vascularization during development. Advances in Experimental Medicine and Biology. 543: 139-49. PMID 14713119 DOI: 10.1007/978-1-4419-8997-0_10 |
0.628 |
|
2001 |
Yue X, Tomanek RJ. Effects of VEGF(165) and VEGF(121) on vasculogenesis and angiogenesis in cultured embryonic quail hearts. American Journal of Physiology. Heart and Circulatory Physiology. 280: H2240-7. PMID 11299227 DOI: 10.1152/Ajpheart.2001.280.5.H2240 |
0.62 |
|
1999 |
Yue X, Tomanek RJ. Stimulation of coronary vasculogenesis/angiogenesis by hypoxia in cultured embryonic hearts. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 216: 28-36. PMID 10474163 DOI: 10.1002/(Sici)1097-0177(199909)216:1<28::Aid-Dvdy5>3.0.Co;2-U |
0.626 |
|
1999 |
Tomanek RJ, Ratajska A, Kitten GT, Yue X, Sandra A. Vascular endothelial growth factor expression coincides with coronary vasculogenesis and angiogenesis. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 215: 54-61. PMID 10340756 DOI: 10.1002/(Sici)1097-0177(199905)215:1<54::Aid-Dvdy6>3.0.Co;2-0 |
0.613 |
|
Show low-probability matches. |